Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Healthcare Biotechnology
Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP... see more

Recent & Breaking News (TSXV:HEM)

Hemostemix Completes Private Placement and Rights Offering

GlobeNewswire August 25, 2017

Hemostemix Inc. Announces Agreement to Resolve all Outstanding Matters with Hemostemix (Asia) Corporation (HEMA)

GlobeNewswire August 17, 2017

Hemostemix Announces Updates on Private Placement

MarketWire Canada August 15, 2017

Hemostemix Announces Updates on Rights Offering

MarketWire Canada August 15, 2017

Hemostemix Announces Updates on Rights Offering and Private Placement

MarketWire Canada July 21, 2017

Hemostemix Announces Engagement of PI Financial Corp., Rights Offering and Updates on Proposed Private Placement and Senior Secured Credit Financing

MarketWire Canada July 11, 2017

Hemostemix Announces Voting Results of the Annual and Special Meeting of Shareholders

Marketwired June 30, 2017

Hemostemix Inc. Announces Update on Status of Agreement with Hemostemix (Asia) Corporation (HEMA)

MarketWire Canada June 9, 2017

Hemostemix Announces CDN$4,400,000 Senior Secured Debt Financing and Plans to Undertake a Private Placement for up to CDN$8,000,000

MarketWire Canada April 10, 2017

Hemostemix Announces Corporate Updates

MarketWire Canada March 22, 2017

IIROC Trading Resumption - HEM; DYU.H; HSI

Canada NewsWire February 9, 2017

IIROC Trade Resumption - Hemostemix Inc.

Newsfile February 9, 2017

Hemostemix Announces Further Progress and the Resumption of Trading

Marketwired February 8, 2017

Acquisition and Disposition of Securities of Hemostemix Inc.

MarketWire Canada January 25, 2017

Hemostemix Announces Reorganization

MarketWire Canada January 25, 2017

Hemostemix Announces Corporate Update

MarketWire Canada January 6, 2017

IIROC Trading Halt - HEM

Canada NewsWire January 6, 2017

IIROC Trade Halt - Hemostemix Inc.

Newsfile January 6, 2017

Hemostemix Announces Corporate Update

MarketWire Canada January 5, 2017

Hemostemix Announces Reorganization

MarketWire Canada December 22, 2016